GMP Services
Dr Valerie Mulholland
Valerie Mulholland is the Principal Consultant and CEO of
GMP Services, Ireland's leading compliance partner for the global life
sciences industry.
With over 25 years of experience, she provides
strategic regulatory training and guidance to clients across the
bio-pharmaceutical, medical device, and blood transfusion sectors in
Ireland, the EU, the US, and Mexico.
Valerie is renowned for her deep
technical knowledge and her practical, solution-oriented approach to
complex quality challenges. Her curiosity as to why the industry had not taken advantages of the opportunities ICH Q9 seemed to offer, led her to begin a PhD with the Pharmaceutical Regulatory Science Team (PRST) in TU Dublin.
The Research Foundation: From Industry Problem to Global Impact
Valerie's work is driven by a
pivotal question:
Why did progress in effective Quality Risk Management
stall after its introduction?
Her
doctoral research tackled this question directly, examining the human,
organizational, and decision-science factors limiting QRM's potential.
This groundbreaking work, which also explored RBDM in other high-risk
industries, produced 13 academic publications and a thesis that became a key reference for global standards.
The Impact
Her research was used to inform the ICH's deliberations on ICH Q9(R1).
It is now referenced in the official ICH Q9(R1) training materials.
In January 2025, she was invited by PIC/s to educate international regulators on ICH Q9(R1) at the EMA headquarters.
Her research was used to inform the ICH's deliberations on ICH Q9(R1).
It is now referenced in the official ICH Q9(R1) training materials.
In January 2025, she was invited by PIC/s to educate international regulators on ICH Q9(R1) at the EMA headquarters.
Current Focus & Industry Leadership
Valerie is at the forefront of the field's evolution, actively shaping its future through research, training, and industry dialogue. Her current explorations include:
Developing on-demand training courses on Decision Science for Pharma, focused on mastering Risk-Based Decision Making.
Continued material development for explainable AI and human-in-the-loop decision making.
Optimizing decision review cadences within the PQS.
Building resilience for high-stakes choices.
Selected Leadership Roles
- Board Member, PDA Global Regulatory Affairs
& Quality Advisory (RAQA).
- Lecturer on RBDM for the Masters in Validation
and Quality Assurance at TU Dublin.
- Co-host of the Risk Revolution podcast.
Translating Theory into Action: Education & Advisory
The Mission
Her mission is clear: to help you build decisions you can defend with confidence, and then scale that capability with technology.
Valerie brings a unique blend of academic rigor, practical clarity, and unparalleled regulatory credibility to every engagement.
Valerie's LinkedIn Blog
In her LinkedIn blog, Valerie dissects complex regulatory concepts into actionable insights, helping to guide decision makers.
Risk Revolution Podcast
Dr Valerie Mulholland,
Published Academic Papers.
PHD Theses, by Valerie Mulholland
Effective Risk-Based Decision Making in Quality Risk
Management
Authors, Mulholland, V., Greene, A. (2024)
Pharmaceutical Technology, Volume 48, No. 4, p 32-39, April 2024
Authors, Mulholland, V. Greene, A., Lipa M. (2023).
KENX Insight, Volume 3, Article 5
Authors, Mulholland, V., Greene, A. (2023). KENX Insight, Volume 3, Article 3
Authors, Mulholland, V., Greene, A. (2023).KENX Insight, Volume 3, Article 4
Authors, Mulholland, V., Greene, A. (2023).KENX Insight, Volume 3, Article 2
Authors, Lipa, M., Mulholland, V., & Greene, A. (2022).Pharmaceutical Engineering, Vol 42, No 4, July-Aug 2022
Authors, Lipa, M., Mulholland, V., & Greene, A. (2022).Technological University Dublin. DOI: 10.21427/DC44-Y431
Authors, Lipa, M., Mulholland, V., O’Donnell, K, & Greene, A. (2022).ISPE Case Studies,
Authors, Mulholland, V; Greene, A; and Lipa, M. (2021)Level 3: Vol. 16: Issue. 1, Article 2. Dec 2021
Authors, Mulholland, V., & Greene, A. (2020).Level 3: Vol. 15: Issue. 2, Article 18. Dec 2020
Authors, Mulholland, V., & Greene, A. (2020).Level 3: Vol. 15: Issue. 2, Article 21. Dec 2020
